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Introduction
Hypernatremia has been known as any 
increased plasma Na concentration up to a value higher 
than 145 mM. This condition is often seen in intensive 
care units (ICUs) and it is mostly developed by admission 
wards. The disease leads to rise mortalities, and it also 
causes an extended length of stay in the ICU ward [1]. 
One of the recent studies on severity and duration of 
hypernatremia after ICU admission indicates that there 
are higher mortality and duration of stay in the ICU ward 
(an increased rate of 40% and 28%, respectively) [2].
A prospective study conducted in the ICU 
ward shows that almost 50% of pre-dialysis patients 
suffering from acute kidney injury (AKI) also have a 
dysnatremia, which is actually hypernatremia, and 
also an increased mortality rate exists particularly for 
severe/acute hypernatremia (a serum sodium of 156) 
in comparison with normonatremic patients (89.1% 
vs. 64.6%, respectively) [3]. In addition, pre-operative 
hypernatremia is relevant to increase perioperative 
30-day mortality and morbidity [4].
To understand hypernatremia, one needs to 
be familiar with the main fluid compartments of the 
body and how those compartments work together. 
Accordingly, total body water (TBW) is known as a 
crucial physiological expression in such an area. TBW 
occupies nearly 60% and 50% of the body weight 
among males and females, respectively. It is also 
divided into two main categories, including extracellular 
fluid (ECF) and intracellular fluid (ICF) [5]. The former 
encompasses interstitial and lymph fluid, plasma, 
transcellular fluid within body cavities, connective tissue 
and bone, and finally adipose tissue while the latter 
occupies two-third of the water in a body [6]. Another 
relevant important concept is tonicity, which points to 
cell volume’s behavior in a specific solution and also 
introduces the effective osmoles’ action throughout a 
membrane. A cellular volume is extended at the time 
cells are bathed in a relatively hypotonic solution and 
contracts when bathed in a relatively hypertonic solution. 
The reason is that water moves inside and outside of 
the cell to achieve tonicity with a stable state. Active/
effective osmoles are glucose and sodium as well as 
related anions in the ECF; this is while the major cation 
of the ICF is potassium and estimations for its serum 
or plasma concentration are not so valuable to infer 
total body potassium. Besides, osmolality introduces 
the total sum of both ineffective and effective osmoles 
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Abstract
Hypernatremia has been known as a conventional electrolyte problem and is defined as a serum sodium concentration 
growth up to a value above 145 mmol/l. This disease is also known as a hyperosmolar condition, which is resulted 
from a reduction in total body water compared to the electrolyte content. Since two types of hypernatremia, including 
acute and chronic, exist, in the present study, we will review the available clinical approaches for the management of 
patients with acute and chronic hypernatremia. To this end, 68 studies having the criteria of the present review and 
published from 2000 were chosen and their data were extracted. The inclusion criterion was to be mainly focused 
on hypernatremia clinical treatment and those having side topics were excluded from the study. Acute symptomatic 
hypernatremia is a disease that occurs in <24 h and needs to be treated immediately. On the other hand, there is 
a chronic hypernatremia that occurs in a duration of more than 48 h and is required to be treated at a lower speed 
due to cerebral edema risks during treatment. Finally, for providing beneficial outcomes to patients, both chronic and 
acute hypernatremia need to be compared thoroughly and also more investigation needs to be done.
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per kg of a body’s fluid. The former osmoles, usually 
alcohol and urea, are able to cross throughout the cell 
membranes freely and thus generally do not lead to a 
cellular volume change. Osmolality is known as a weak 
sign of tonicity following to existence of such ineffective-
type osmoles. Whereas the impacts of tonicity on 
cellular size might not be direct, serum sodium may act 
as a useful surrogate for tonicity in all parts of the body 
in a stable state [7].
Hypertonicity or dehydration points to the TBW 
loss in such a way that cellular volume contracts, while 
volume depletion is an expression that is employed to 
represent ECF loss. These two individual conditions 
lead to both different clinical specifications and 
therapeutic reactions [8], [9].
On the other hand, according to a comparison 
between hypernatremia and hyponatremia, it can be 
said that the former signifies a water deficit relative to 
sodium and may be resulted from few causes, including 
insufficient free water intake, free water losses, and, more 
seldom overload of sodium (all elaborated in etiology 
section). In contrast to hyponatremia, hypernatremia 
always points to serum hyperosmolality [10].
As a result, hypernatremia permanently 
depicts hypertonic hyperosmolality and continually 
leads to cellular dehydration or transient dehydration, 
while chronic plasma hypertonicity correction through 
rehydration therapy can point to herniation, brain 
swelling, and even death [10]. The clinical differences 
between acute and chronic hypernatremia can be 
realized by considering the different mechanisms 
through which the cells inside the brain adjust their 
volume in a reaction to brief and sustained osmotic 
challenges [11]. For this reason and also for the 
significance of hypernatremia, the present study 
reviewed the clinical approaches for the management 
of patients with acute and chronic hypernatremia. In the 
methodology section, we initially provide some details 
on etiology and pathophysiology as well as causes of 
this disease, and then, we explain the treatment and 
clinical approaches.
Methods
The present study is actually a qualitative work 
and a careful review and critical analysis of the medical 
literature. We undertook several searches in such 
authoritative online databases as PubMed, MEDLINE, 
Link of Springer, Online Library of Wiley, Science Direct 
of Elsevier, Cambridge Core, and Cochrane. To this 
end, the special keywords (i.e., hypernatremia, acute 
hypernatremia, chronic hypernatremia, hypernatremia 
management, and hypernatremia diagnosis, clinical 
approaches for hypernatremia, and etiology of 
hypernatremia) associated with the subject of this review 
were determined, based on which the searches were 
conducted. The time range of the investigated content is 
limited from 2000 to 2019. Accordingly, 68 studies having 
the criteria of the present review and published from 2000 
were chosen and their data were extracted. The inclusion 
criterion was to be mainly focused on hypernatremia 
clinical treatment and above-mentioned keywords and 
those having side topics were excluded from the study.
Etiology
Hypernatremia is a water problem. In other 
words, it usually points to inaccessibility of water or 
when there is a disorder or damage in thirst mechanism. 
The primary causes of hypernatremia could be divided 
into the following groups:
• Free water losses:
• Osmotic diuresis/renal losses (e.g., poorly 
controlled diabetes mellitus, being recovoered 
from renal failure, intravenous mannitol/
loop diuretics use, diabetes insipidus, being 
recovered from obstructive uropathy) [12], [13]
• Gastrointestinal losses (e.g., profuse 
diarrhea secondary to treatment with 
activated charcoal/sorbitol for poisoning, 
prolonged vomiting/severe diarrhea, sodium 
polystyrene sulfonate/sorbitol use among 
patients suffering from hyperkalemia) [14]
• Insensible or sweat losses (e.g., burns, 
exercise, heat exposure, and fever) may not 
lead to acute hypernatremia, but they can 
worsen the hypernatremia [15]
• Within peritoneal dialysis, where the high 
dextrose dialysates are used (seen among 
patients unable to normally drink water) [16]
• Inadequate/insufficient free water intake:
• Being unable to drink water or limited water 
accessibility (e.g., older patients who have 
dementia) [16]
• Impaired thirst mechanism 
(e.g., granulomatous disease, primary 
hypodipsia due to brain tumors, congenital 
hypothalamic lesions, and the existence of 
subfornical organ-targeting antibody) [17].
It is noteworthy to mention that those suffering 
from hypernatremia show a deficit in free water 
intake, in the two conditions explained above, the 
only abnormality that is seen among them is either 
they are unable to drink water or they are inaccessible 
to water due to the disorders of their body system, 
inaccessibility/limited accessibility to water or the 
impaired thirst mechanism [18].
• Sodium overload:
• Prescription of high volumes of solutions of 
hypertonic sodium bicarbonate (e.g., patients 
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who are suffering from metabolic acidosis) or 
hypertonic saline [19].
• Surplus use of mineralocorticoid 
(e.g., Cushing syndrome and primary 
aldosteronism), whereas hypernatremia 
is usually mild and such patients typically 
suffer from a concomitant abnormality in 
their water accessibility, developing an 
acute hypernatremia [20]
• Salt intake at a high volume (e.g., inadvertent 
infusion with 5% saline, deliberate ingestion 
of household-strength bleach, improperly 
high concentration of either sodium chloride 
or sodium bicarbonate in dialysate for 
the treatment of hemodialysis, seawater 
drowning [thereof in survivors], and ingestion 
of bamboo salt or general excessive salt 
ingestion which usually occurs among 
children/pediatric patients when salt might 
be mistaken for sugar) [21], [22].
According to the details of the etiology of 
hypernatremia, as mentioned earlier, Figure 1 depicts a 
diagram of possible etiologies of this disease.
cases and is X-linked, a low rate of patients 
has mutations in the aquaporin 2 collecting 
duct (AQP2) gene [27].
• Central/hypothalamic:
• Acquired: A history of traumatic brain injury or 
any other damage to the brain (e.g., infections, 
vascular syndromes, aggressive surgery 
for craniopharyngioma, tumors, Rathke 
cleft cyst, or other types of hypothalamic 
tumors) often exists [19]. In a study, for the 
1st time, two case studies having apparent 
temozolomide-induced central diabetes 
insipidus were described [28]. Temozolomide 
(an alkylating agent) is active in the central 
nervous system, may improve the treatment 
of advanced metastatic melanoma [29]. 
Faje et al. [28] concluded that, although the 
prevalence of central diabetes insipidus is 
rare, it may be referred to as a reversible side 
effect of treatment with temozolomide. This 
type of diabetes insipidus is relevant to acute 
myelogenous leukemia, as well [30].
• Congenital: This is rarely seen [27].
Dexmedetomidine, a sedative used before 
and within surgical procedures, is reported to result in 
polyuria and urinary concentrating defect through a not 
known mechanism, which can lead to partial central or 
nephrogenic diabetes insipidus [31].
Pathophysiology
In general, the serum sodium concentration 
(Na+) could be considered as a function of the total 
exchangeable sodium and potassium in the body as the 
TBW. In doing so, hypernatremia may merely develop 
as a result of either a loss of free water or a gain of 
sodium or a combination of both. Nevertheless, a high 
percentage of patients with hypernatremia are still 
hypervolemic despite a high urine output; this is due 
to formerly received vast amounts of normal saline and 
being massively edematous [32], [33].
Both urinary loss and diarrhea may lead to 
hypernatremia. In the case of the former, electrolyte-
free water excretion (also referred to as electrolyte-free 
water clearance) is found through the following equation 
known as electrolyte-free water excretion formula [34].
N a K
N a
U + UV × (1 - )
P
Where,
V denotes urine flow rate, UNa refers to sodium’s 
urine concentration (mEq/L), UK shows potassium’s 
urine concentration (mEq/L), and PNa denotes plasma 
concentration of sodium (mEq/L).
Figure 1: Possible etiologies of hypernatremia
As mentioned above, dementia patients 
usually suffer from a concomitant infection, and free 
water losses and inadequate free water intake may be 
seen concurrently [23].
Nevertheless, diabetes insipidus is an 
unconventional reason for hypernatremia incidence 
since the patient’s thirst mechanism is intact enough to 
tackle electrolyte abnormalities development [13]. Two 
types of diabetes insipidus exist:
• Nephrogenic:
• Acquired: Causes include specific drugs 
(e.g., demeclocycline, lithium, cisplatin, 
foscarnet, amphotericin B, aminoglycosides, 
Vitamin A or D excess, penicillin derivatives, 
vinblastine, colchicine, and vasopressin 
receptor antagonists) [24], [25], amyloidosis, 
sickle cell disease, obstructive uropathy, 
additional tubulointerstitial diseases, 
hypercalcemia, and hypokalemia [26]
• Congenital: Although it is resulted from a 
mutation at the corresponding gene for the 
receptor vasopressin (V2) in the majority of 
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A negative or positive value can be obtained 
for electrolyte-free water excretion [24]:
• UNa + UK <PNa (Positive): A process tending to 
increase the concentration of serum sodium
• UNa + UK >PNa (Negative): A process tending to 
decrease the concentration of serum sodium.
Where, UNa, UK, and PNa denote sodium’s urine 
concentration, potassium’s urine concentration, and 
sodium’s plasma concentration, respectively.
The people who have a normal renal function 
and also the individuals who receive huge amounts of 
saline are likely to focus their urine on excreting their 
received sodium load, and, as a result, they will have 
minimal electrolyte-free water excretion. Nevertheless, 
patients with diabetes insipidus or kidney dysfunction 
are not able to excrete the extra sodium load and are 
likely to develop hypernatremia [19], [35], [36].
In an acute type of hypernatremia (typically 
characterized by the onset of signs <48 h), the higher 
osmolality in the extracellular space will lead the water 
to move out of brain cells and thus resulting in shrinkage 
of the brain. Such shrinkage may result in neurological 
outcomes, including weakness, lethargy, and irritability. 
In the case of severe types, adverse manifestations 
may contain seizures, intracranial hemorrhage, coma, 
stupor, and death [19], [37]. Chronic hypernatremia 
(typically developing over >48 h) causes fewer 
variations in brain cell volume since the brain cells 
can be matched with the chronic hyperosmolality 
through increased intracellular osmolality. Brain 
cells accomplish it first by accumulating potassium 
chloride and sodium chloride and then by increasing 
intracellular brain solutes including taurine, glutamate, 
and myoinositol [37], [38].
In central type of diabetes insipidus, no 
vasopressin (which is also referred to as arginine 
vasopressin or antidiuretic hormone) exists due 
to a congenital/acquired condition which impairs 
vasopressin synthesis. Nevertheless, in nephrogenic 
type of diabetes insipidus, the kidneys provide no 
proper response to the secretion of vasopressin [39].
Patients with hypernatremia mostly have a 
high creatinine level and blood urea nitrogen (BUN). 
The high BUN level may make the hypernatremia 
worse through an osmotic diuresis. Therefore, the 
amounts of potassium and sodium excreted in the urine 
will be relatively small (i.e., UNa + UK <PNa), increasing 
the excretion/clearance of electrolyte-free water [40].
Treatment
As in other diseases, the treatment of 
hypernatremia should be first undertaken by addressing 
the primary causes and then taking appropriate 
actions (e.g., treating fever, stopping the offending 
medication, relieving the urinary obstruction, giving 
insulin, and discontinuing the sodium sources), as well 
as substitution of any free water deficit and ongoing 
fluid losses, and simultaneously, keeping an eye on 
serum sodium concentration to make sure all levels 
are returning to the correct range at the desired rate. 
However, no consensus exists on the ideal correction 
rate. Rapid correction of concentration of the serum 
sodium is of high importance due to the cerebral 
edema’s risk; in contrast, an investigation indicated 
that prolonged correction of concentration of the 
serum sodium could be harmful, as well [41]. Another 
systematic review reports an absence of good-quality 
evidence (observational controlled or randomized 
trials) for active correction of hypernatremia among 
resuscitated patients who are recovered from a critical 
disease [42].
On the other hand, the following factors can be 
pointed out as risk factors of hypernatremia:
• Advanced age
• Uncontrolled diabetes (solute diuresis)
• Mental or physical impairment
• Diuretic therapy
• Primary polyuria disorders
• Hospitalization
• Residency in nursing home, inadequate 
nursing care [10].
Treatment strategy
In all patients, the primary treatment strategy 
involves the following steps:
• Making the deficiency of free water calculated
• Estimating proceeding losses of free water (if 
applicable)
• Determining a suitable serum sodium 
correction rate
• Designing a suitable fluid repletion program 
that takes into account the estimated free water 
deficit, the desired serum sodium correction 
rate, and any ongoing free water losses
• More specific treatment is guided by the 
existence of signs or symptoms, severity of 
symptoms, time of onset, and volume status of 
the patient [10].
Severe or acute hypernatremia must always be 
treated in hospital, whereas mild/chronic hypernatremia 
can be controlled in the outpatient conditions, as 
well [10].
Chronic hypernatremia
Most of the patients with hypernatremia are 
suffering from chronic type. The brain matches itself to 
hypernatremia through idiogenic osmoles generation. It 
is a protective mechanism that begins on the 1st day 
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and continues to be completed within a few days, and 
it decreases cerebral edema. Due to the prevalence 
and importance of the chronic type of hypernatremia, 
first, we elaborate the chronic hypernatremia and its 
different types as follows:
Chronic hypernatremia is categorized into 
three main forms: Hypovolemic, euvolemic, and 
hypervolemic, each of which has specific treatment 
considerations [43]. Figure 2 compares each mentioned 
form.
through the following equation (inferred of the Edelman 
equations): Water deficiency = TBW × (ongoing 
concentration of serum sodium/140−1). This equation 
helps to estimates the amount of positive water balance 
needed to take the concentration of serum sodium back 
to 140 mEq/L, while traditional approaches recommend 
to replace half of the calculated water deficiency within 
the first 24 h and the rest within the next 48–72 h [48].
Another equation, also inferred from the 
Edelman equations, was reported by Madias and 
Adrogué and Madias [10]. It is broadly employed in 
clinical settings for the management of hypernatremia 
and also has been investigated prospectively in the 
management of patients suffering from hypernatremia, 
particularly chronic ones [49].
in fusa te serum[N a + K ] - [N a ][N a ] =
T o ta lbody w ate r + 1
∆
The equation mentioned above estimates the 
forecasted impact of retaining 1 L of the prescribed 
solution on the concentration of serum sodium. 
Application of either the former or latter formula needs 
body weight to measure and estimate TBW accurately. 
Furthermore, such a formula is not considered for 
current losses, which might change considerably over 
the treatment course. Both losses, including renal and 
extrarenal, need to be taken into consideration and also 
included in the overall fluid administration [10], [50]. 
Such data provide the conditions for individual analysis 
of the net balance of water, potassium, and sodium. 
Proper regulation in the fluid administration needs to 
be directed through frequent evaluation of the clinical 
status of the patient as well as serial monitoring of 
laboratory values within the treatment. This mostly 
pertains to iterated serum sodium measurements every 
6–8 h over the initial therapy [51].
Although hypervolemic hypernatremia accounts 
for the least conventional form of hypernatremia, it 
is regarded as an excessive prescription of sodium 
(hypertonic saline solution infusion, hypertonic sodium 
bicarbonate, and accidental salt overloading) [52]. 
In this case, the replacement of non-renal losses or 
hypotonic urinary with isotonic solutions leads to a 
hypertonic solution’s net retention and hypernatremia 
development. This scenario may happen over the 
treatment of some common disorders, including burns, 
septic/hypovolemic shock, prolonged nasogastric 
suction, uncontrolled sorts of diabetes, and being 
recovered from severe azotemia [7], [46]. Hypervolemic 
type of hypernatremia is identified recently in critical 
care conditions [46]. Balance investigations on water 
and electrolytes (i.e., tonicity balance studies) approve 
such a fact that the mentioned issue is basically due to 
the prescription of isotonic fluids within the context of 
weak maximal urinary concentrating ability, along with 
the associated limitation of water intake [50]. This issue 
is elaborated as “shallow content of water and very high 
content of salt” [46].
Figure 2: Hypernatremia caused by variations in total body water and 
total body sodium. The circles in black introduce the sodium (Na) [10]
Furthermore, enhanced plasma osmolality due 
to hypernatremia leads to water movement outside the 
brain cells and will thus cause shrinkage of the brain 
cells. Next, the brain will experience some adaptive 
processes which aim at additional solutes’ accumulation 
to recover the volume of the brain, which is composed 
of slower organic osmolytes’ accumulation and rapid 
inorganic ions’ accumulation. Such an adaptive process 
for chronic hypernatremia is considered for the incidence 
of lower neurologic signs/symptoms in a comparison to 
acute hypernatremia with similar severity [44]. While a 
patient is being recovered from chronic hypernatremia, 
the brain’s organic solute content will be slowly back 
to normal levels within 24–48 h. As a result, chronic 
hypernatremia correction needs to occur gradually for 
the prevention of rapid fluid motions into the brain cells 
and the relevant development of cerebral edema [45]. 
Most specialists recommend not to exceed sodium 
correction from 0.5 mEq/L/h to 10–12 mEq/L/d among 
patients suffering from hypernatremia for the duration 
above 24 h [44]. Nevertheless, no randomized trial is 
available to support such a recommendation. Studies 
conducted on animals and children/pediatric patients 
report that quicker rates may result in neurologic 
symptoms [46], [47]. The ingredients and composition of 
the fluid, which is supposed to be given, is considerably 
dependent on the lost fluid type and any simultaneous 
electrolyte disorders. The water deficiency, which 
is presented with pure water loss (no change in the 
total content of cation in the body), may be estimated 
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Here, some case presentations for chronic 
hypernatremia are discussed as follows:
An analysis undertaken on 130 critical patients 
suffering from hypernatremia indicated that in a rate of 
92% of cases, hypernatremia was seen over an ICU 
stay, and the primary cause relevant to hypernatremia 
was loss in renal water. Deficient correction, with 
shallow content of free water and very high content of 
the hypertonic solution, accompanied these cases, as 
well [46]. Such a mechanism is revealed in a patient 
in Robertson et al. [47] during a representative 24 h 
period when he required aggressive fluid resuscitation. 
In this case report, Al-Absi et al. [48] evaluated a 
73-year-old man with obesity who was presented with 
severe hypotension due to acute/severe bleeding in 
lower gastrointestinal. The disease that was diagnosed 
in this patient was a hypervolemic hypernatremia 
type. The patient carried on the restricted mobility and 
reduced sensation of thirst, which left him with a high 
risk of experiencing chronic hypernatremia. In the time 
of the study, the family members of mentioned patient 
provided him with a time planned fluid intake. In the 
follow-up phase, the concentration of serum sodium 
was 145 mEq/L (145 mmol/L).
The development and treatment of 
hypervolemic hypernatremia in the patient investigated 
by Al-Absi et al. [48] are presented in Tables 1 and 2.
undertaking the hemodialysis [51]. Correction of both 
diseases, including hypervolemia and hypernatremia, 
can be done only on an excess of a negative sodium and 
potassium balance from a negative water equilibrium/
balance [53]. Prescription of furosemide alone causes 
excretion of urine with an osmolality content of ~300 
mOsm/kg and urinary sodium in addition to the 
concentrations of potassium as many as ~100 mEq/L. 
This fact reveals that excretion of water exceeds 
that of cation, resulting in worsened hypernatremia. 
Prescription of 5% dextrose in water and furosemide 
may result in resolution of either hypernatremia or 
hypervolemia [53].
The key role of accurate measurement of body 
weight and the succeeding estimation of TBW is clear 
because any failure to acquire iterated measurements 
of body weight may result in remarkable mistakes in 
TBW estimation. In addition, the TBW, estimated as 
0.6 × body weight, is valid merely for healthy males at 
relatively younger ages. Among female cases and the 
elderly ones, 0.5 × body weight is considered as a closer 
approximation for TBW under euvolemic circumstances. 
In the case of dehydration in a patient with older ages, 
another adjustment of 0.4 × body weight will make the 
approximation of TBW more closely [54].
The following items have been represented as 
the risk factors of the development of hypernatremia: 
Restricted mobility, weakened thirst, limited access to 
water, a urinary concentrating defect associated with 
a chronic kidney injury, and non-renal losses from 
the ileostomy as well as AKI which often escorts the 
hypernatremia, specifically in the case of diarrhea 
or osmotic diuresis with depletion of intravascular 
volume [55]. Although AKI is hardly ever considered 
as the direct source of hypernatremia, it might play 
a role in its development through restricted urinary 
concentrating capability from weakened medullary 
hypertonicity generation [56].
The beginning step for the treatment of 
hypernatremia consists of the administration of 
isotonic saline solution for 18–24 h to put back the 
hemodynamics. This kind of fluid therapy will lead to 
no variation in concentration of serum sodium [48]. The 
Table 1: Development of hypervolemic hypernatremia in the 
patient investigated by Al-Absi et al. [48] according to the 
effect of isotonic saline solution administration and effect of 
furosemide with either fluid restriction or water replacement
Effect of isotonic saline solution administration
24 h intake: 4.0 L of isotonic saline; 4×154 mEq/L=616 mEq of sodium
24 h output: 2.0 L of urine; urine osmolality 350 mEq/L
Urine sodium plus potassium concentration (lost in urine)= ∼100 mEq/L; 2×100 
mEq=200 mEq
Net positive cation balance: 616–200=416 mEq
Net positive water balance: 4.0–2.0=2.0 L
Tonicity of retained fluid: 416 mEq/2.0 L=208 mEq/L, which would increase 
[Na] ∼1.0 mEq/L
Effect of furosemide with either fluid restriction or water replacement:
Before furosemide administration: Serum sodium concentration: 146 mEq/L
Body weight=113 kg; TBW=0.6×113 kg=68 L; note: 0.6×body weight used due to 
generalized edema
Total body cation content: 68 L×146 mEq/L=9928 mEq
24 h water intake: <1.0 L, similar to insensible and stool losses
24 h output: 4.0 L of urine; urine sodium plus potassium concentration=∼100 mEq/L
Net cation balance: 0 intake−4×100 mEq/L=−400 mEq
Net water balance: ∼0–4 L=−4 L
New total body cation content: 9928–400=9528 mEq; new TBW=64 L
Predicted new serum sodium concentration: 9528 mEq/64 L=149 mEq/L
Measured serum sodium concentration after furosemide was 149 mEq/L
If 2 L of water were administered and retained, net water balance would be−2.0 L
New TBW=66 L; predicted serum sodium concentration: 9528/66=144 mEq/L
Administration and retention of 4.0 L of water: 9528/68=140 mEq/L with no change in TBW
Alternative analysis (assuming a 4.0 L relative water deficit): Furosemide yields a urine 
Na + K of ∼100 mEq/L, which can be considered equivalent to excretion of 0.67 L of 
isotonic saline solution and 0.33 L of free water. Replacement of such urine output 1:1 
with free water would result in the addition of 0.67 L of water per 1 L of urine output. Thus, 
the replacement of 6.0 L of urine output with 6.0 L of free water would be necessary to 
correct the 4.0 L water deficit over the desired time frame, assuming no other losses
TBW: Total body water.
Treatment of hypervolemic hypernatremia has 
two goals: (1) Achievement of water equilibrium and 
negative sodium for the correction of hypervolemia and 
(2) gradual correction of hypernatremia. These goals 
can be achieved through restriction of sodium, diuresis 
with loop diuretics along with water replacement, or 
Table 2: Treatment procedure of hypervolemic hypernatremia 
in the patient investigated by Al-Absi et al. [48] in two settings
Setting 1: A 73-year-old man with [Na+] of 163 mmol/L, body weight of 94 kg, 
TBW=0.4×94=37.6 La; selected solution is 0.9% normal saline (sodium concentration, 
154 mEq/L)
[Na ] mEq / L /1 Lof  infusate+
serum



 
154 163
37 6 1
0 23
.
.
Patient received 3.0 L of 0.9% normal saline solution
Predicted Δ[Na+]serum=∼−0.7 mEq/L
Observed Δ[Na+]serum=∼0.0 mEq/L
Setting 2: Subsequent therapy with dextrose 5% in water as replacement solution
[Na ] mEq / L /1 Lof  infusate+
serum



 
0 163
37 6 1
4 2
.
.
For a goal of Δ[Na+]serum of 10 mEq/L/24 h, 10/4.2=2.3 L of infusate required; given 
the patient’s estimated ongoing losses (GI and insensible losses of ∼2.0 L), the rate of 
infusion becomes 4300 mL/24 h=179 mL/h
Predicted Δ[Na+]serum=∼−10 mEq/L
Observed Δ[Na+]serum=−7.0 mEq/L
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next therapy based on 5% dextrose in water will result 
in successive correction of concentration of serum 
sodium within 48 h [48]. Too rapid correction of chronic 
hypernatremia is considerably regarded as high risk; 
however, some observational investigations have also 
indicated that a gradual correction of hypernatremia 
over the first 24 h is likely to result in a higher rate 
of mortality [57]. As a result, another therapy as the 
alternative may be a prescription of 1–2 L of normal 
saline solution for quick restoration of plasma volume 
on hypotonic fluids for the promotion of hypernatremia 
correction [58].
Intravenous replacement of free water as 5% 
dextrose in water is typically nominated versus oral free 
water intake for euvolemic hypernatremia management 
among hospitalized patients. The hyperglycemia caused 
by 5% dextrose in water might not be seen in the case 
of infusion rates of <300 mL/h. Nevertheless, one of 
the necessary solutions may be insulin therapy, which 
is employed for the prevention of hyperglycemia and 
osmotic diuresis among diabetic patients. Intravenous 
solution with 0.22% sodium chloride is reported to be 
applied successfully as a replacement fluid; however, 
a small risk of hemolysis is possible followed by using 
this solution [58].
Overall, every chronic type of hypernatremia 
is likely to be treated securely and efficiently through 
sound quantitative evaluation and clinical reasoning of 
output and intake, specifically output of urine. All types 
of hypernatremia somehow point to an absolute or 
relative water loss. In doing so, the primary control and 
management of this disease will be to identify the main 
reason for hypernatremia and correct specification of the 
volume status and body weight of the patient to provide 
the conditions to calculate the water insufficiency. 
Classification of chronic hypernatremia into three 
categories, including hypovolemic, euvolemic, and 
hypervolemic, allows us to have a beginning point to 
formulate what type and rate of fluid are supposed to 
be prescribed. Continual clinical evaluation as well as 
serial laboratory/experimental data are necessary to 
make sure of hypernatremia’s gradual correction up to 
a value of ~0.5 mEq/L in each hour, not a value above 
10 mEq/L within 24 h [10].
Furthermore, in another case study, a patient 
suffering from chronic hypernatremia but not having thirst 
sensation was investigated. This patient was presented 
with weakness of muscles to whom water intake was 
the administration method which led to successful 
treatment. This approach is considerably challenging 
but gave rise to the reduction of serum sodium with 
resolution of all symptoms of the patient [59].
Acute hypernatremia
The following steps are to be taken for cases 
with acute hypernatremia [10]:
• A report should be established for disease 
onset. It should be noted that the acute form is 
<24 h, and the chronic form is above 24 h
• The serum sodium should be corrected at a 
primary rate of 2–3 mEq/L/h (for a duration of 
2–3 h) (maximum total value of 12 mEq/L/d)
• Every 1–2 h, the serum and urine electrolytes 
should be measured
• Serial neurologic examinations should be 
undertaken and the rate of correction should 
be reduced with improvement in symptoms
• In the event of existence of volume deficiency 
and hypernatremia, intravascular volume 
needs to be restored by isotonic sodium 
chloride before administration of free water [10]
• Patients need to be provided with intravenous 
5% dextrose, in case of patients’ inability for 
oral water toleration [58].
Other recommendations for chronic 
hypernatremia are also recommended and applicable 
for acute type. In addition, training of ambulatory care is 
recommended to facilitate looking after such patients in a 
hospital [60] and in orthopedic ward [61], [62], [63], [64].
Conclusion
Acute hypernatremia is the disease happening 
at a duration of <24 h and needs to be corrected quickly. 
On the other hand, chronic hypernatremia (<48 h) is 
required to be corrected gradually and in lower speed 
due to cerebral edema risks during treatment. Finally, 
this area needs more prospective investigations to 
compare interventions for both chronic and acute 
hypernatremia to beneficial outcomes for such patients.
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